eXtended Antibiotic Prophylaxis for Intermediate- and High-risk Glands After Pancreatoduodenectomy to Reduce CR-POPF

NCT05753735 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Principal investigator left the institution.

Conditions

Pancreatic Fistula

Interventions

DRUG: Piperacillin/Tazobactam
DRUG: Amoxicillin/ Clavulanic acid

Sponsor

Case Comprehensive Cancer Center